Apelin receptor agonists and methods of use thereof
US10647689B2 · kind B2 · utility
2Cited by
2References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 28, 2016 |
| Grant date | May 12, 2020 |
| Priority date | — |
| Expiry date | Apr 28, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Provided herein are agonists of the apelin receptor for the treatment of disease. The compounds disclosed herein are useful for the treatment of a range of cardiovascular, renal and metabolic conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.